Curebound raises $8.3M Grant (United States, Jun 2026)
$8.3M
$8.25 millionGenerated social card
Headline
Concert for Cures Series Surpasses $28 Million Raised for Cancer Research Following P!NK’s Electrifying Performance at Petco Park - BioSpace
About
Curebound is a community-powered cancer research accelerator dedicated to advancing breakthrough science into cures. It focuses on funding high-impact cancer studies and fostering collaborations among scientists, advocates, and philanthropists to improve cancer prevention, detection, and treatment.
Article summary
Concert for Cures Series Surpasses $28 Million Raised for Cancer Research Following P!NK’s Electrifying Performance at Petco Park BioSpace
Founder
Robin Toft
CEO
Investors
Related rounds
| Aug 14, 2026 | MiiHealth AI | $2.8M | — | United States |
| Aug 14, 2026 | Alloy Robotics | $8.0M | Pre-seed | United States |
| Aug 14, 2026 | Zipline | $950.0M | Debt | United States |
| Aug 14, 2026 | InduPro | $77.0M | Series B | United States |